Developing mRNA medicines to restore protein function.

We are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat, or prevent, debilitating or life-threatening diseases

Learn More

Translate Bio

We are pioneering the translation of mRNA therapeutics into transformative medicines.

Watch the Video

Recent News

02.25 2021
Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress
02.18 2021
Translate Bio to Present at the SVB Leerink Virtual 10th Annual Global Healthcare Conference
02.03 2021
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01.07 2021
Translate Bio Announces Timing of Interim Results from mRNA Therapeutic Clinical Trial in Patients with Cystic Fibrosis; Data Expected in Early Q2 2021

View All

@TranslateBio